Effect of an oral α2-adrenergic blocker (MK-912) on pancreatic islet function in non-insulin-dependent diabetes mellitus
- 1 November 1991
- journal article
- clinical trial
- Published by Elsevier in Metabolism
- Vol. 40 (11) , 1160-1167
- https://doi.org/10.1016/0026-0495(91)90210-n
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Pharmacological profile of a new potent and specific ?2-adrenoceptor antagonist, L-657,743Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1987
- Exaggerated peripheral responses to catecholamines contributes to stress-induced hyperglycemia in the ob/ob mousePharmacology Biochemistry and Behavior, 1987
- Studies of midaglizole (DG-5128). A new type of oral hypoglycemic drug in healthy subjectsDiabetes, 1987
- Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1984
- Effects of α‐adrenoceptor antagonists on clonidine‐induced inhibition of insulin secretion by isolated pancreatic isletsBritish Journal of Pharmacology, 1983
- Assessment of α2 adrenergic autoreceptor function in humans: Effects of oral yohimbineLife Sciences, 1982
- Adrenergic mechanisms in the hyperglycaemia and hyperinsulinaemia of diabetic KK miceDiabetologia, 1981
- Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose IntoleranceDiabetes, 1979
- A role for alpha-adrenergic receptors in abnormal insulin secretion in diabetes mellitus.Journal of Clinical Investigation, 1976
- Failure of Sulfonylureas to Suppress Plasma Glucagon in ManDiabetes, 1972